Tectonic Therapeutic, Inc. (TECX) › Cash & EquivalentsTectonic Therapeutic, Inc. (TECX) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2017: $5.96M2018: $126.30M2019: $187.04M2020: $259.68M2021: $189.57M2022: $92.56M2023: $28.77M2024: $141.24M2025: $253.80M$253.80M2017Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$253.80M+79.7%2024$141.24M+390.9%2023$28.77M-68.9%2022$92.56M-51.2%2021$189.57M-27.0%2020$259.68M+38.8%2019$187.04M+48.1%2018$126.30M+2018.1%2017$5.96M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share